Skip to main content

Figure 4  .

Figure 4  

(A) Liver biopsy at day 102 after commencing adefovir dipivoxil 10 mg daily showing complete resolution of cholestasis, a marked decrease in inflammation, and regression of fibrosis (stage 2). (B) Liver immunohistochemistry at day 102 after commencing adefovir dipivoxil 10 mg daily demonstrating negative staining for hepatitis B surface antigen while hepatitis B core antigen was found in occasional hepatocyte nuclei but not in the cytoplasm.